Gilead Sciences Presents Findings from Clinical Studies Evaluating Patients Who Switched to Biktarvy(R) at 2020 Asia Pacific AIDS & Co-infections Conference

Studies in Asian women and adult population found people living with HIV switching to Biktarvy® from baseline regimen sustained viral suppression and tolerability

HONG KONG, Oct. 15, 2020 /PRNewswire/ -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced findings from multiple studies in Asian population that evaluated the safety and...

Read more: Gilead Sciences Presents Findings from Clinical Studies Evaluating Patients Who Switched to Biktarvy...

More Articles …

  1. Lumen Launches Managed Endpoint Detection and Response Service in Asia Pacific-PR Newswire APAC
  2. SBW) Smart Shelves for Autonomous Retail Drive Casino Groupe New Automated Store in Paris-PR Newswire APAC
  3. Mölnlycke launches new skin-friendly Biogel® surgical gloves to reduce the risk of allergic contact dermatitis for surgeons and nurses
  4. Nintex Completes Acquisition of K2 Software, Inc.-PR Newswire APAC
  5. Growth acceleration accompanied by 3.7% YoY margin expansion; revenue and margin guidance increased to 2%-3% in cc and 23%-24% respectively-PR Newswire APAC
  6. Planon signs partnership with MazeMap-PR Newswire APAC
  7. Exiger Announces Global Expansion of Exiger Intelligence-PR Newswire APAC
  8. Fondazione Prada Presents "Human Brains," A Multidisciplinary Project Dedicated To Brain Studies-PR Newswire APAC
  9. Enapter Chooses Germany for Electrolyser Mass-Production Site-PR Newswire APAC
  10. THOMAS SABO and Rita Ora inspire with Magic Stars Collection-PR Newswire APAC